+Vote!
Medical News Today (Free subscription) | 12 hours ago
Updated guidance published in the current issue of the American Society of Hypertension's (ASH) Journal of Clinical Hypertension addresses the urgent need for physicians to take a more integrated, individualized approach to treating hypertension (high blood pressure) in patients with diabetes by treating the intricacies of each patient profile, rather than focusing on the disease in isolation.
+Vote!
Medical News Today (Free subscription) | yesterday
Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.
+Vote!
Medical News Today (Free subscription) | yesterday
MyCareTeam has announced that through a relationship with The Barton Center for Diabetes Education that its popular diabetes management software product, MCT-Diabetes, will be used extensively going forward with the management of its campers at the Barton Camp in Oxford, MA and the Joslin Camp in Charlton, MA.
+Vote!
Medical News Today (Free subscription) | yesterday
Diamyd Medical reports that the world's most influential medical journal, the New England Journal of Medicine, has published an article with results from the company's study of the Diamyd(R) diabetes vaccine for type 1 diabetes. The article is now available on the journal's web site (http://www.nejm.org) and will be in print on October 30.
+Vote!
Medical News Today (Free subscription) | 08/10/2008
By killing off "angry" immune cells that take up residence in obese fat and muscle tissue, researchers have shown that they can rapidly reverse insulin resistance in obese mice. The findings reported in the October Cell Metabolism, a publication of Cell Press, suggest that treatments aimed at specific subsets of the so-called macrophage cells might offer a very effective new antidiabetic therapy, according...
+Vote!
Medical News Today (Free subscription) | 08/10/2008
Building on mounting evidence that implicates infection-fighting cells found in obese fat tissue in the growing problem of insulin resistance and Type 2 diabetes, researchers at the University of California, San Diego, School of Medicine have identified a particular subset of cells that are linked to obesity-associated insulin resistance, and that offer a promising new target for the treatment of diabetes....
+Vote!
Medical News Today (Free subscription) | 07/10/2008
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr. Barbara Troupin, Senior Director of Clinical Development, announced the data in a poster presentation titled "The...
+Vote!
Medical News Today (Free subscription) | 07/10/2008
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome. Dr. Donald Garrow and Dr.
+Vote!
Medical News Today (Free subscription) | 07/10/2008
Genaera Corporation (Nasdaq: GENR) reported data from its second Phase 1 clinical trial of trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity. MSI-1436 is a novel inhibitor of PTP1B, a validated molecular target that controls the function of both the leptin and insulin pathways to normalize glucose and decrease appetite.
+Vote!
Medical News Today (Free subscription) | 06/10/2008
To understand where fat comes from, you have to start with a skinny mouse. By using such a creature, and observing the growth of fat after injections of different kinds of immature cells, scientists at the Howard Hughes Medical Institute and Rockefeller University have discovered an important fat precursor cell that may in time explain how changes in the numbers of fat cells might increase and lead...
+Vote!
Medical News Today (Free subscription) | 06/10/2008
The Empire State Stem Cell Board has awarded research planning grants to Albert Einstein College of Medicine and to Montefiore Medical Center. The grants, totaling $238,000, are part of $2 million in grants announced by State Health Commissioner Richard F. Daines, M.D.
+Vote!
Medical News Today (Free subscription) | 03/10/2008
Brown University, with lead partner Women & Infants Hospital of Rhode Island, has been awarded a $12-million, five-year contract to expand its participation in the National Children's Study, a groundbreaking research project aimed at improving child health. The National Institute of Child Health and Human Development (NICHD), one of the 27 Institutes and Centers at the National Institutes of Health,...
+Vote!
Medical News Today (Free subscription) | 03/10/2008
Ark Therapeutics Group plc ("Ark" or the "Company") today announces that it has successfully achieved reimbursement from the UK NHS Business Services Authority for Neuropad®, an innovative diagnostic test to detect early stage peripheral autonomic neuropathy in the feet of diabetic patients. Neuropad® is the first product in a new diagnostic class to be available to the NHS on prescription.
+Vote!
Medical News Today (Free subscription) | 02/10/2008
Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases of aging such as Type 2 Diabetes, mitochondrial disorders, inflammation, cancer, and heart disease.
+Vote!
Medical News Today (Free subscription) | 01/10/2008
British diabetes care is the 2nd best in Europe, according to the first Euro Consumer Diabetes Index. Denmark leads the Index ranking, UK being the runner-up, only one point behind and ahead of France. The outcome is a welcome advance from the UK's performance in the last European Health Consumer Index, where they were ranked 17th, and the Heart Index, where they were placed 9th.
